Skip to main content
SpringerLink
Log in

Apoptosis

Clinical Relevance and Pharmacological Manipulation

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Apoptosis, often synonymously used with the term ‘programmed cell death’, is an active, genetically controlled process that removes unwanted or damaged cells.

Suppression, overexpression or mutation of a number of genes which orchestrate the apoptotic process are associated with disease. The diseases in which apoptosis has been implicated can be grouped into 2 broad groups: those in which there is increased cell survival (i.e. associated with inhibition of apoptosis) and those in which there is excess cell death (where apoptosis is overactive).

Diseases in which there is an excessive accumulation of cells include cancer, autoimmune disorders and viral infections. Deprivation of trophic factors is known to induce apoptosis in cells dependent on them for survival. This fact has been exploited in the use of antiandrogens or antiestrogens in the management of prostate or breast cancer.

Haemopoietic growth factors like granulocyte-macrophage colony stimulating factor (GM-CSF) or interleukin-3 prevent apoptosis in target cells and modulation of levels of these factors has been tried in the prevention of chemotherapy-induced myelosuppression. Until recently, it was thought that cytotoxic drugs killed target cells directly by interfering with some life-maintaining function. However, of late, it has been shown that exposure to several cytotoxic drugs with disparate mechanisms of action induces apoptosis in both malignant and normal cells.

Physiological regulation of cell death is essential for the removal of potentially autoreactive lymphocytes during development and the removal of excess cells after the completion of an immune response. Recent work has clearly demonstrated that dysregulation of apoptosis may underlie the pathogenesis of autoimmune diseases by allowing abnormal autoreactive lymphocytes to survive.

AIDS and neurodegenerative disorders like Alzheimer’s or Parkinson’s disease represent the most widely studied group of disorders where an excess of apoptosis has been implicated. Amyotrophic lateral sclerosis, retinitis pigmentosa, epilepsy and alcoholic brain damage are other neurological disorders in which apoptosis has been implicated.

Apoptosis has been reported to occur in conditions characterised by ischaemia, e.g. myocardial infarction and stroke. The liver is a site where apoptosis occurs normally. This process has also been implicated in a number of liver disorders including obstructive jaundice. Hepatic damage due to toxins and drugs is also associated with apoptosis in hepatocytes. Apoptosis has also been identified as a key phenomenon in some diseases of the kidney, i.e. polycystic kidney, as well as in disorders of the pancreas like alcohol-induced pancreatitis and diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239–57

    PubMed  CAS  Google Scholar 

  2. Herman Steller. Mechanisms and genes of cellular suicide. Science 1995; 267: 1445–9

    Google Scholar 

  3. Cohen JJ. Apoptosis. Immunol Today 1993; 14(3): 126–30

    PubMed  CAS  Google Scholar 

  4. Kerr JFR, Harmon BV. Definition and incidence of apoptosis: an historical perspective. In: Tomie LD, Cope FO, editors. Apoptosis: the molecular basis of cell death. Cold Spring Harbor: Laboratory Press, 1991: 5–29

    Google Scholar 

  5. Carson DA, Rebeiro JM. Apoptosis and disease. Lancet 1993; 341: 1251–4

    PubMed  CAS  Google Scholar 

  6. Singh N. Apoptosis — new concepts in molecular medicine. Ind J Clin Biochem 1995; 10(2): 54–6

    Google Scholar 

  7. Kontogeorgos G, Kovacs K. Apoptosis in endocrine glands. Endocrine Pathology 1995; 6: 257–65

    PubMed  Google Scholar 

  8. Schwartzman RA, Cedlowski JA. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr Rev 1993; 14(2): 133–51

    PubMed  CAS  Google Scholar 

  9. Arends MJ, Wyllie AH. Mechanisms and roles in pathology. Int Rev Exp Pathol 1991; 32: 223–54

    PubMed  CAS  Google Scholar 

  10. Arends MJ, Morris RG, Wyllie AH. Apoptosis: the role of the endonuclease. Am J Pathol 1990; 36: 593–608

    Google Scholar 

  11. Wyllie AH. Glucocorticoid induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284: 555–6

    PubMed  CAS  Google Scholar 

  12. Bortner CD, Oldenburg NBS, Cedlowski JA. The role of DNA fragmentation in apoptosis. Trends Cell Biol 5: 21–6

  13. Knight CR, Rees RC, Griffin M. Apoptosis: a potential role for cytosolic transglutaminase and its importance in tumour progression. Biochem Biophys Acta 1991; 1096: 312–8

    PubMed  CAS  Google Scholar 

  14. Gavrieli Y, Sherman Y, Bensasson SA. Identification of programmed cell death in situ via special labelling of nuclear DNA fragments. J Cell Biol 1992; 119: 493–501

    PubMed  CAS  Google Scholar 

  15. Kokawa K, Toshihiko S, Ryosuke N. Apoptosis in the human uterine endometrium during the menstrual cycle. J Clin Endocrinol Metab 1996; 81(11): 4144–7

    PubMed  CAS  Google Scholar 

  16. Hamel W, Dazin P, Israel M. Adaptation of a simple flow cytometric assay to identify different stages during apoptosis. Cytometry 1996; 25: 173–81

    PubMed  CAS  Google Scholar 

  17. Dive C, Gregory CD, Phipps DJ, et al. Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochem Biophys Acta 1992; 1133: 275–85

    PubMed  CAS  Google Scholar 

  18. Gong J, Traganos F, Darsynkiewicz Z. A selective procedure for DNA extracting from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal Biochem 1994; 218: 314–9

    PubMed  CAS  Google Scholar 

  19. McConkey DJ, Hartzeil P, Duddy SK, et al. 2,3,7,8-tetrachlorobenzo-p-dioxin kills immature thymocytes by calcium mediated endonuclease activation. Science 1988; 242: 256–9

    PubMed  CAS  Google Scholar 

  20. Gregory CD, Dive C, Henderson S, et al. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 1991; 349: 612–4

    PubMed  CAS  Google Scholar 

  21. Majno G, Joris I. Apoptosis, oncosis and necrosis: an overview of cell death. Am J Pathol 1995; 146(1): 3–15

    PubMed  CAS  Google Scholar 

  22. Lowe S, Bodis S, McClatchey A, et al. p53 status and efficacy of cancer treatment in vivo. Science 1994; 266: 807–10

    PubMed  CAS  Google Scholar 

  23. Appleby DW, Modak SP. DNA degradation in terminally differentiating lens fibre from chick embryos. Proc Natl Acad Sci USA 1977; 74: 5579–83

    PubMed  CAS  Google Scholar 

  24. Darzynkiewicz Z, Bruno S, Del Bino G, et al. Features of apoptotic cells measured by flow cytometry. Cytometry 1992; 13: 795–808

    PubMed  CAS  Google Scholar 

  25. Telford WG, King LE, Fraker PJ. Rapid quantitation of apoptosis in pure and heterogeneous cell populations using flow cytometry. J Immunol Method 1994; 172: 1–16, 25

    CAS  Google Scholar 

  26. Frankfurt OS. Detection of apoptosis in leukemic and breast cancer cells with monoclonal antibody to single stranded DNA. Anticancer Res 1994; 14(5A): 1861–9

    PubMed  CAS  Google Scholar 

  27. Ellis PA, Smith IE, McCarthy K, et al. Preoperative chemotherapy induces apoptosis in early breast cancer [letter]. Lancet 1997; 349: 849

    PubMed  CAS  Google Scholar 

  28. Moreira LF, Naomoto Y, Hamada M, et al. Assessment of apoptosis in esophageal carcinoma preoperative treatment by chemotherapy and radiology. Anticancer Res 1995; 15(2): 639–44

    PubMed  CAS  Google Scholar 

  29. Chen DF, Schneider GE, Martinou J-C, et al. Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature 1997; 385: 434–9

    PubMed  CAS  Google Scholar 

  30. Vaux DL, Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci USA 1996; 93: 2239–44

    PubMed  CAS  Google Scholar 

  31. White E. Life, death and the pursuit of apoptosis. Genes Dev 1996; 10: 1–15

    PubMed  CAS  Google Scholar 

  32. Linn SC, Honkoop AH, Hockman K, et al. p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis. Br J Cancer 1996; 74: 63–8

    PubMed  CAS  Google Scholar 

  33. Aas T, Borresen AL, Geisler S, et al. Specific p53 imitations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat Med 1996; 2(7): 811–4

    PubMed  CAS  Google Scholar 

  34. Hockenbery DM, Zutler M, Hickey W, et al. Bcl-2 protein is topographically restricted in tissues characterised by apoptotic death. Proc Natl Acad Sci USA 1991; 88: 6961–5

    PubMed  CAS  Google Scholar 

  35. Vaux DL, Cory S, Adams J. Bcl-2 promotes haemopoietic cell survival and cooperates with c-myc to immortalise pre-beta cells. Nature 1988; 335: 440–2

    PubMed  CAS  Google Scholar 

  36. Boise LH, Gonzalez-Garcia M, Postema CE, et al. bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptosis death. Cell 1993; 74: 597–608

    PubMed  CAS  Google Scholar 

  37. Muchmore SW, Sattler M, Liang H, et al. X-ray and NMR structure of human bcl-x, an inhibitor of programmed cell death. Nature 1996; 381: 335–41

    PubMed  CAS  Google Scholar 

  38. Minn AJ, Velez P, Schendek SL, et al. Bcl-xL forms on ion channel in synthetic lipid membranes. Nature 1997; 385: 353–7

    PubMed  CAS  Google Scholar 

  39. Lefebre S, Burglen L, Reboullet S, et al. Identification and characterization of a spinal muscular atrophy determining gene. Cell 1995; 80: 155–65

    Google Scholar 

  40. Anderson GP. Resolution of chronic inflammation by therapeutic induction of apoptosis. Trends Pharmacol Sci 1996; 17(12): 438–42

    PubMed  CAS  Google Scholar 

  41. Ashwell JD., Berger NA, Cidlowski JA, et al. Coming to terms with death: apoptosis in cancer and immune development. Immunol Today 1994; 15(4): 147–51

    PubMed  CAS  Google Scholar 

  42. Vogelstein B. A deadly inheritance. Nature 1990; 348: 681–2

    PubMed  CAS  Google Scholar 

  43. Bardeesy N, Beckwith JB, Perretier J. Clonal expansion and attenuated apoptosis in Wilms’ tumour are associated with p53 mutations. Cancer Res 1995; 55: 215–9

    PubMed  CAS  Google Scholar 

  44. Newcomb EW. p53 gene mutations in lymphoid diseases and their possible relevance to drug resistance. Leuk Lymphoma 1995; 17: 211–21

    PubMed  CAS  Google Scholar 

  45. Iwadate Y, Fujimoto S, Tagawa M, et al. Association of p53 gene mutation with decreased chemosensitivity in human gliomas. Int J Cancer 1996; 69(3): 236–40

    PubMed  CAS  Google Scholar 

  46. Evan GI, Wyllie AH, Gilbert CS, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69: 119–28

    PubMed  CAS  Google Scholar 

  47. Anderson GP. Bcl-2 related proteins, apoptosis and disease [comment]. Trends Pharmacol Sci 1997; 18: 51

    PubMed  CAS  Google Scholar 

  48. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456–62

    PubMed  CAS  Google Scholar 

  49. Watson AJM. Necrosis and apoptosis in the gastointestinal tract. Gut 1995; 37: 165–7

    PubMed  CAS  Google Scholar 

  50. Merritt AJ, Potten CS, Kemp CJ, et al. The role of p53 in spontaneous and radiation induced apoptosis in the gastrointestinal tract of normal and p53 deficient mice. Cancer Res 1994; 54: 614–7

    PubMed  CAS  Google Scholar 

  51. Bursch W, Oberhammer F, Schulte-Hermann R. Cell death by apoptosis and its protective role in disease. Trends Pharmacol Sci 1992; 13(6): 245–51

    PubMed  CAS  Google Scholar 

  52. Mullauer I, Grasl-Kraupp B, Bursch W, et al. Transforming growth factor beta-1 induced cell death in preneoplastic foci of rat liver and sensitization by the anti-estrogen tamoxifen. Hepatology 1996; 23(4): 840–7

    PubMed  CAS  Google Scholar 

  53. Sugarman PR, Joseph BK, Savage NW. The role of oncogenes, tumour suppressor genes and growth factors in oral squamous cell carcinoma: a case of apoptosis vs proliferation. Oral Dis 1995; 1: 172–88

    Google Scholar 

  54. Masunnaga A, Arai T, Yoshitake T, et al. Reduced expression of apoptosis-related antigens in thymuses from patients with myasthenia gravis. Immunol Lett 1994; 39(2): 169–72

    Google Scholar 

  55. Aringer M, Wintersberger W, Steiner CW, et al. High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus. Arthritis Rheum 1994; 37(10): 1423–30

    PubMed  CAS  Google Scholar 

  56. Woolley KL, Gibson PG, Carty K, et al. Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am J Respir Crit Care Med 1996; 154: 237–43

    PubMed  CAS  Google Scholar 

  57. Lee FD. Importance of apoptosis in the histopathology of drug related lesions in the large intestine. J Clin Pathol 1993; 46(2): 118–22

    PubMed  CAS  Google Scholar 

  58. Grigg JM, Savill JS, Sarraf C, et al. Neutrophil apoptosis and clearance from neonatal lungs. Lancet 1991; 338: 720–2

    PubMed  CAS  Google Scholar 

  59. Gagliardini V, Hannes P, Drexler CA, et al. Prevention of vertebrate neuronal death by the crm A gene. Science 1994; 263: 826–8

    PubMed  CAS  Google Scholar 

  60. Pantaleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993; 328: 327–32

    PubMed  CAS  Google Scholar 

  61. Ameisen JC, Capron A. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol Today 1991; 12(4): 102–5

    PubMed  CAS  Google Scholar 

  62. Terai C, Kornbluth RS, Pauza CD, et al. Apoptosis as a mechanism of cell death in cultured T lymphocytes acutely infected with HIV-1. J Clin Invest 1991; 87: 1710–4

    PubMed  CAS  Google Scholar 

  63. Gschwind M, Huber G. Apoptotic cell death induced by beta-amyloid 1–42 peptide is cell type dependent. J Neurochem 1995; 65(1): 292–300

    PubMed  CAS  Google Scholar 

  64. Festoff BW. Amyotrophic lateral sclerosis: current and future treatment strategies. Drugs 1996; 51(1): 28–44

    PubMed  CAS  Google Scholar 

  65. Walkinshaw G, Waters CM. Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA: implications for the treatment of Parkinson’s disease. J Clin Invest 1995; 95(6): 2458–64

    PubMed  CAS  Google Scholar 

  66. Dipasquale B, Marini AM, Youle RJ. Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons. Biochem Biophys Res Commun 1991; 181(3); 1442–8

    PubMed  CAS  Google Scholar 

  67. Portera-Cailliau C, Sung CH, Nathans J, et al. Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc Natl Acad Sci USA 1994; 91(3): 974–8

    PubMed  CAS  Google Scholar 

  68. Pollard H, Cantagrel S, Charriaut MC, et al. Apoptosis associated DNA fragmentation in epileptic brain damage. Neuroreport 1994; 5(9): 1053–5

    PubMed  CAS  Google Scholar 

  69. Freund G. Apoptosis and gene expression: perspectives on alcohol induced brain damage. Alcohol 1994: 11(5): 385–7

    PubMed  CAS  Google Scholar 

  70. Cartwright MM, Smith SM. Increased cell death and reduced neural crest cell numbers in ethanol-exposed embryos: partial basis for the fetal alcohol syndrome phenotype. Alcohol Clin Exp Res 1995; 19(2): 378–86

    PubMed  CAS  Google Scholar 

  71. Selleri C, Maciejewski JP, Sato T, et al. Interferon gamma constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent haemopoietic inhibition. Blood 1996; 87(10): 4149–57

    PubMed  CAS  Google Scholar 

  72. Laurence J, Mitra D, Steiner M, et al. Apoptotic depletion of CD4+ T cells in idiopathic CD4+ T lymphocytopenia. J Clin Invest 1996; 97(3): 672–80

    PubMed  CAS  Google Scholar 

  73. Yuan J, Angelucci E, Lucarelli G, et al. Accelerated programmed cell death (apoptosis) in erythroid precursors of patients with severe beta-thalassemia (Cooley’s Anemia). Blood 1993: 82(2): 374–7

    PubMed  CAS  Google Scholar 

  74. Efferth TH, Fabry U, Glatte P, et al. Increased induction of apoptosis in mononuclear cells of a G6PD deficient patient. J Mol Med 1995: 73(1): 47–9

    PubMed  CAS  Google Scholar 

  75. Hatfill BJ, Fester ED, Steytler JG. Apoptotic megakaryocyte dysplasia in the myelodysplastic syndrome. Hematol Pathol 1992: 6(2): 87–92

    PubMed  CAS  Google Scholar 

  76. Home WI, Tsukamoto H. Dietary modulation of alcohol induced pancreatic injury. Alcohol 1993; 10(6): 481–4

    Google Scholar 

  77. Katz AM. The cardiomyopathy of overload: an unnatural growth response. Eur Heart J 1995; 16 Suppl. O: 110–4

    PubMed  Google Scholar 

  78. Lam TT, Fu J, Hrynewycz M, et al. The effect of aurintricarboxylic acid, an endonuclease inhibitor, on ischemia/ reperfusion damage in rat retina. J Ocul Pharmacol Ther 1995; 11: 253–9

    PubMed  CAS  Google Scholar 

  79. Kischer CW. The microvessels in hypertrophie scars, keloids and related lesions: a review. J Submicrosc Cytol Pathol 1992; 24(2): 281–96

    PubMed  CAS  Google Scholar 

  80. James TN, Terasaki F, Pavlovich ER, et al. Apoptosis and pleomorphic micromitochondriosis in the sinus nodes surgically excised from five patients with the long QT syndrome. J Lab Clin Med 1993: 122(3): 309–23

    PubMed  CAS  Google Scholar 

  81. Kwo P, Patel T, Bronk SF, et al. Nuclear serine protease activity contributes to bile acid-induced apoptosis in hepatocytes. Am J Physiol 1995: 268: G613–21

    PubMed  CAS  Google Scholar 

  82. Zalewski PD, Forbes IJ, Betts WH. Correlation of apoptosis with change in intracellular labile Zn (II) using zinquin. Biochem J 1993; 296: 403–8

    PubMed  CAS  Google Scholar 

  83. Seigers C-P. Anthranoid laxatives and colorectal cancer. Trends Pharmacol Sci 1992; 13(6): 229–31

    Google Scholar 

  84. Geboes K, Spiessens C, Nijs G, et al. Anthranoids and the mucosal immune system of the colon. Pharmacology 1993; 47: 49–57

    PubMed  CAS  Google Scholar 

  85. Walker NI, Bennett RE, Axelsen RA. Melanosis coli a consequence of anthraquinone induced apoptosis of colonic epithelial cells. Am J Pathol 1988; 131: 465–76

    PubMed  CAS  Google Scholar 

  86. Holmgren L, O’Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995; 1(2): 149–53

    PubMed  CAS  Google Scholar 

  87. Kyprianou N. Apoptosis: therapeutic significance in the treatment of androgen dependent and androgen independent prostate cancer. World J Urology 1994; 12(6): 299–303

    CAS  Google Scholar 

  88. Baral E, Nagy E, Berczi I. Modulation of natural killer cell mediated cytotoxicity by tamoxifen and estradiol. Cancer 1995; 75(2): 591–9

    PubMed  CAS  Google Scholar 

  89. Kang Y, Cortina R, Perry RR. Role of c-myc in tamoxifen-induced apoptosis in estrogen independent breast cancer cells. J Natl Cancer Inst 1996; 88(5): 279–84

    PubMed  CAS  Google Scholar 

  90. Perry RR, Kang Y, Greaves BR. Relationship between tamoxifen induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells. Br J Cancer 1995; 72: 1441–6

    PubMed  CAS  Google Scholar 

  91. Iwasaki K, Toms SA, Barnett GH, et al. Inhibitory effects of tamoxifen and tumour necrosis factor alpha on human glioblastoma cells. Cancer Immunol Immunother 1995; 40(4): 228–34

    PubMed  CAS  Google Scholar 

  92. Yano T, Korkut E, Pinski J, et al. Inhibition of growth of MCF-7 MIII human breast carcinoma in nude mice by treatment with agonists or antagonists of LH-RH. Breast Cancer Res Treat 1992; 21(1): 35–45

    PubMed  CAS  Google Scholar 

  93. Kleinman D, Douvdeyani A, Schally AV, et al. Direct growth inhibition of human endometrial cancer cells by the gonadotropin-releasing hormone antagonist SB-75; role of apoptosis. Am J Obstet Gynecol 1994; 170: 96–102

    PubMed  CAS  Google Scholar 

  94. Szepeshazi K, Lapis K, Schally AV. Effect of combination treatment with analogs of LHRH or somatostatin and 5FU on pancreatic cancer in hamsters. Int J Cancer 1991; 49(2): 260–6

    PubMed  CAS  Google Scholar 

  95. Smets LA, van den Berg JD. Bcl-2 expression and gluco-corticoid induced apoptosis of leukemic cells and lymphoma cells. Leuk Lymphoma 1996; 20: 199–205

    PubMed  CAS  Google Scholar 

  96. Alnemri ES, Fernandes TF, Haldar S, et al. Involvement of bcl2 in glucocorticoid induced apoptosis in pre-B-leukemias. Cancer Res 1992; 52(2): 491–5

    PubMed  CAS  Google Scholar 

  97. Shwartzman RA, Cidlowsky JA. Mechanism of tissue specific induction of internucleosomal DNA cleavage activity and apoptosis by glucocorticoids. Endocrinology 1993; 133(2): 591–9

    Google Scholar 

  98. McConkey DJ, Orrenius S, Okret S, et al. cAMP potentiates the glucocorticoid induced endonuclease activation in thymocytes. FASEB J 1993; 7(6): 580–5

    PubMed  CAS  Google Scholar 

  99. Brach MA, d Vos S, Gruss HJ, et al. Prolongation of survival of human PMN by GM-CSF is caused by inhibition of programmed cell death. Blood 1992; 80: 2920–4

    PubMed  CAS  Google Scholar 

  100. Bergamaschi G, Rosti V, Danova M, et al. Inhibitors of tyrosine phosphorylation induces apoptosis in human leukemic cell lines. Leukemia 1993; 7(12): 2012–8

    PubMed  CAS  Google Scholar 

  101. Collins MK, Marvel J, Malde P, et al. IL-3 protects bone marrow cells from apoptosis induced by DNA damaging agents. J Exp Med 1992; 176(4): 1043–51

    PubMed  CAS  Google Scholar 

  102. Usha D, Thatte UM, Dahanukar SA. Therapeutic potential of the hemopoietic growth factors. J Postgrad Med 1994; 40(4): 210–5

    PubMed  CAS  Google Scholar 

  103. Kaplinksky C, Lotem J, Sachs L. Protection of human myeloid leukemia cells against doxorubicin-induced apoptosis by granulocyte-macrophage colony stimulating factor and interleukin-3. Leukemia 1996; 10(3): 460–5

    Google Scholar 

  104. Bessho M, Yoshida S, Sakate K, et al. Suppression of the development of murine myeloid leukemia with granulocyte colony stimulating factor by inducing apoptosis of leukemic cells. Leukemia 1994; 8(7): 1185–90

    PubMed  CAS  Google Scholar 

  105. Bhalla K, Tang C, Ibrado AM, et al. GM-CSF/IL-3 fusion protein (pIXY 321) enhances high dose Ara-C induced programmed cell death or apoptosis in human myeloid leukemia cells. Blood 1992; 80(11): 2883–90

    PubMed  CAS  Google Scholar 

  106. Tang C, Huang Y, Ponnathpur VS, et al. Combined antileukemic activity of pIXY 321 and Ara-C against human acute myeloid leukemia cells. Leuk Lymphoma 1994; 15: 445–51

    PubMed  CAS  Google Scholar 

  107. Fluckiger AC, Durand I, Banchereau J. Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. J Exp Med 1994; 179(1): 91–9

    PubMed  CAS  Google Scholar 

  108. Capelli E, Barni S, Vaccarone R, et al. Cell activation and death (apoptosis) induced by IL-2: ultrastructural evidence. Anti-cancer Res 1996; 16: 1775–80

    CAS  Google Scholar 

  109. Novelli P, Garotta G, Forni G. Environmental signals influencing expression of the IFN-gamma receptor on human T cells control whether IFN-gamma promotes proliferation or apoptosis. J Immunol 1994; 152(2): 496–504

    PubMed  CAS  Google Scholar 

  110. Kitabayashi A, Hirokawa M, Miura AB. The role of interleukin-10 (IL-10) in chronic B-lymphocytic leukemia: IL-10 prevents leukemic cells from apoptotic cell death. Int J Haematol 1995; 62: 99–106

    CAS  Google Scholar 

  111. Tisman G, Show-Jen GW. Lithium-induced leucocytosis. Lancet 1977; II: 251–2

    Google Scholar 

  112. Mediehe AM, Mampuru LJ, Tyobeka EM. Induction of apoptosis in HL-60 cells by lithium. Biochem Biophys Res Commun 1995; 209(2): 768–74

    Google Scholar 

  113. Wood AC, Elvin P, Hickman JA. Induction of apoptosis by anti-cancer drugs with disparate modes of action: kinetics of cell death and changes in c-myc expression. Br J Cancer 1995; 71(5): 937–41

    PubMed  CAS  Google Scholar 

  114. Neubauer A, Thiede C, Huhn D, et al. p53 and induction of apoptosis as a target for anticancer treatment. Leukemia 1996; 10(3): 52–4

    Google Scholar 

  115. Stoetzer OJ, Nussler V, Darsow M, et al. Association of bcl-2, bax, bcl-xL, IL-1 beta converting enzyme expression with initial response to chemotherapy treatment in acute myeloid leukemia. Leukemia 1996; 10(S3): 318–22

    Google Scholar 

  116. Maung ZT, MacLean FR, Reid MM, et al. The relationship between bcl-2 expression and response to chemotherapy in acute leukemia. Br J Haematol 1994; 88: 105–9

    PubMed  CAS  Google Scholar 

  117. Segal-Bendirdjian E, Jacquemin-Sablon A. Cisplatin resistance in a murine leukemia cell line is associated with a defective apoptotic process. Exp Cell Res 1995; 218(1): 201–12

    PubMed  CAS  Google Scholar 

  118. Benhatter J, Cerottini JP, Saraga E, et al. p53 mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomas. Int J Cancer 1996; 69(3): 190–2

    Google Scholar 

  119. Gruber J, Greil R. Apoptosis and therapy of malignant diseases of the hematological system. Int Arch Allergy Immunol 1994; 105: 368–73

    PubMed  CAS  Google Scholar 

  120. Kondo S, Yin D, Takeuchi J, et al. Bcl2 gene enables rescue from in vitro myelosuppression (bone marrow cell death) induced by chemotherapy. Br J Cancer 1994; 70: 421–6

    PubMed  CAS  Google Scholar 

  121. Singh N. Apoptotic cell death and cancer therapy. Drugs: News and Views 1994

  122. Gillio-Tos A, Cignetti A, Rovera G, et al. Retroviral vector-mediated transfer of the tumour necrosis factor alpha gene into human cancer cells restores an apoptotic cell death program and induces a bystander-killing effect. Blood 1996; 87: 2486–95

    PubMed  CAS  Google Scholar 

  123. Jones KD, Couldwell WT, Hinton DR, et al. Lovastatin induces growth inhibition and apoptosis in human malignant glioma cell lines. Biochem Biophys Res Commun 1994; 205(3): 1681–7

    PubMed  CAS  Google Scholar 

  124. Cotter TG. Programmed to die: cell death in the immune system. Immunologist 1993; 1(6): 181–4

    Google Scholar 

  125. Vaux DL. Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci USA 1993; 90: 786–9

    PubMed  CAS  Google Scholar 

  126. Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994; 152(7): 3685–92

    PubMed  CAS  Google Scholar 

  127. Mountz JD, Wu J, Cheng J, et al. Autoimmune disease: a problem of defective apoptosis. Arthritis Rheum 1994; 37(10): 1415–20

    PubMed  CAS  Google Scholar 

  128. Zetti UK, Gold R, Toyka KV, et al. Intravenous glucocorticoid treatment augments apoptosis of inflammatory T cells in experimental autoimmune neuritis. J Neuropathol Exp Neurol 1995; 54(4): 540–7

    Google Scholar 

  129. Spinozzi F, Agea E, Bistoni O, et al. T lymphocytes bearing the gamma delta T cell receptor are susceptible to steroid induced programmed cell death. Scand J Immunol 1995; 41: 504–8

    PubMed  CAS  Google Scholar 

  130. Racke MK, Critchfield ZM, Quigley L, et al. Intravenous antigen administration as a therapy for autoimmune demyelinating disease. Ann Neurology 1996; 39: 46–56

    CAS  Google Scholar 

  131. Suzuki S, Okubo M, Kaise S, et al. Gold sodium thiomalate selectively inhibits IL-5 mediated eosinophils. J Allergy Clin Immunol 1995; 96(2): 251–6

    PubMed  CAS  Google Scholar 

  132. Miesel R, Kurpisz M, Kroger H. Modulation of inflammatory arthritis by inhibition of poly (ADP ribose) polymerase. Inflammation 1995; 19: 379–87

    PubMed  CAS  Google Scholar 

  133. Fadok VA, Savill JS, Haslett C, et al. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognise and remove apoptotic cells. J Immunol 1992; 149(12): 4029–35

    PubMed  CAS  Google Scholar 

  134. Zhang YH, Takahashi K, Jiang GZ, et al. In vivo induction of apoptosis (programmed cell death) in mouse thymus by administration of lipopolysaccharide. Infect Immun 1993; 61(12): 5044–8

    PubMed  CAS  Google Scholar 

  135. Mangan DF, Mergenhagen SE, Wahl SM. Apoptosis in human monocytes: possible role in chronic inflammatory diseases. J Periodontol 1993; 64: 461–6

    PubMed  CAS  Google Scholar 

  136. Mannick EE, Bravo IE, Zarama G, et al. Inducible nitric oxide synthase, nitrotyrosine and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res 1996; 56(14): 3238–43

    PubMed  CAS  Google Scholar 

  137. Umehara F, Nakamura A, Izumo S, et al. Apoptosis of T lymphocytes in the spinal cord lesions in HTLV-I associated myelopathy: a possible mechanism to control viral infection in the central nervous system. J Neuropathol Exp Neurol 1994; 53(6): 617–24

    PubMed  CAS  Google Scholar 

  138. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J Immunol 1995; 154(9): 4719–25

    PubMed  CAS  Google Scholar 

  139. Aoshiba K, Nagai A, Konno K. Erythromycin shortens neutrophil survival by accelerating apoptosis. Antimicrob Agents Chemother 1995; 39(4): 872–7

    PubMed  CAS  Google Scholar 

  140. Lu X, Xie W, Reed D, et al. NSAIDs cause apoptosis and induce cyclooxygenase in chicken fibroblasts. Proc Natl Acad Sci USA 1995; 92: 7961–5

    PubMed  CAS  Google Scholar 

  141. Akbar AN, Salmon M, Janossy G. Role of bcl-2 and apoptosis in viral infections. Int Arch Allergy Immunol 1994; 105(4): 359–62

    PubMed  CAS  Google Scholar 

  142. Akbar AN, Savill J, Gombert W, et al. The specific recognition by macrophages of CD8+, CD45RO+ T cells undergoing apoptosis: a mechanism for T cell clearance during resolution of viral infections. J Exp Med 1994; 180(5): 1943–7

    PubMed  CAS  Google Scholar 

  143. Groux H, Torpier G, Monte D, et al. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992; 175: 331–40

    PubMed  CAS  Google Scholar 

  144. Banda NK, Berrier J, Kurahara DK, et al. Crosslinking CD4 by human immunodeficiency virus gp 120 primes T cells for activation induced apoptosis. J Exp Med 1992; 38: 252–6

    CAS  Google Scholar 

  145. Mitra D, Steiner M, Lynch DH, et al. HIV-1 upregulates Fas ligand expression in CD4+ T cells in vitro and in vivo: association with Fas-mediated apoptosis and modulation by aurintricarboxylic acid. Immunology 1996; 87: 581–5

    PubMed  CAS  Google Scholar 

  146. Finkel TH, Tudor WG, Banda NK, et al. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV and SIV infected lymph nodes. Nat Med 1995; 1(2): 129–34

    PubMed  CAS  Google Scholar 

  147. Famularo G, De Simone C. A new era for carnitine? Immunol Today 1995; 16(5); 211–3

    PubMed  CAS  Google Scholar 

  148. Huss R, Hoy CA, Ottinger H, et al. Cyclosporine induced apoptosis in CD4+ T lymphocytes and computer simulated analysis: modeling a treatment scenario for HIV infection. Res Immunol 1995; 146(2): 101–8

    PubMed  CAS  Google Scholar 

  149. Thomson AW, Bonham CA. Inhibition of T lymphocyte activation and apoptotic cell death by cyclosporin A and tacrolimus (FK 506): its relevance to therapy of HIV infection. Adv Exp Med Biol 1995; 374: 211–6

    PubMed  CAS  Google Scholar 

  150. Lu W, Salerno-Goncalves R, Yuan J, et al. Glucocorticoids rescue CD4+ T lymphocytes from activation induced apoptosis triggered by HIV-1: implications for pathogenesis and therapy. AIDS 1995; 9: 35–42

    PubMed  CAS  Google Scholar 

  151. Yang Y, Bailey J, Vacchio MS, et al. Retinoic acid inhibition of ex vivo human immunodeficiency virus associated apoptosis of peripheral blood cells. Proc Natl Acad Sci USA 1995; 92(7): 3051–5

    PubMed  CAS  Google Scholar 

  152. Forloni G, Chiesa R, Smiroldo S, et al. Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25–35. Neuroreport 1993; 4(5): 523–6

    PubMed  CAS  Google Scholar 

  153. Branconnier RJ, Branconnier ME, Walshe TM, et al. Blocking the Ca (2+) activated cytotoxic mechanisms of cholinergic neuronal death: a novel treatment strategy for Alzheimer’s disease. Psychopharmacol Bull 1992; 28(2): 175–8

    PubMed  CAS  Google Scholar 

  154. Fang J, Zuo DM, Yu PH. Lack of protective effect of R (()-deprenyl on programmed cell death of mouse thymocytes induced by dexamethasone. Life Sci 1995; 57(1): 15–22

    PubMed  CAS  Google Scholar 

  155. Mitchell IJ, Lawson S, Moser B, et al. Glutamate-induced apoptosis results in a loss of striatal neurons in the parkinsonian rat. Neuroscience 1994; 63(1): 1–5

    PubMed  CAS  Google Scholar 

  156. Walkinshaw G, Waters CM. Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis. Neuroscience 1994; 63(4): 975–87

    PubMed  CAS  Google Scholar 

  157. Bonfoco E, Krainc D, Ankarcrona M, et al. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 1995; 92(16): 7162–6

    PubMed  CAS  Google Scholar 

  158. Neff NT, Prevette D, Houenou LJ, et al. Insulin-like growth factors: putative muscle-derived trophic agents that promote motoneuron survival. J Neurobiol 1993; 24(12): 1578–88

    PubMed  CAS  Google Scholar 

  159. Ferrari G, Yan CY, Greene LA. N-acetylcysteine (D- and L-stereoisomers) prevents apoptotic death of neuronal cells. J Neurosci 1995; 15(4): 2857–66

    PubMed  CAS  Google Scholar 

  160. Garcia I, Martinou I, Tsujimoto Y, et al. Prevention of programmed cell death of sympathetic neurons by bcl-2 protooncogene. Science 1992; 258: 302–4

    PubMed  CAS  Google Scholar 

  161. Vaux DL, Wacker G. Hypothesis: apoptosis caused by cytotoxins represents a defensive response that evolved to combat intracellular pathogens. Clin Exp Pharmacol Physiol 1995; 22: 861–3

    PubMed  CAS  Google Scholar 

  162. Patel T, Gores GJ. Apoptosis and hepatobiliary disease. Hepatology 1995; 21(6): 1725–41

    PubMed  CAS  Google Scholar 

  163. Goldin RD, Hunt NC, Clark J, Wickramsinghe SN. Apoptotic bodies in a murine model of alcoholic liver disease: reversibility of ethanol-induced changes. J Pathol 1993; 171(1): 73–6

    PubMed  CAS  Google Scholar 

  164. Cascales M, Alvarez A, Gasco P, et al. Cocaine-induced liver injury in mice elicits specific changes in DNA ploidy and induces programmed death of hepatocytes. Hepatology 1994; 20: 992–1001

    PubMed  CAS  Google Scholar 

  165. Woo D. Apoptosis and loss of renal tissue in polycystic kidney diseases. N Engl J Med 1995; 333: 18–25

    PubMed  CAS  Google Scholar 

  166. Morgan MG, Cable HC, Newcombe NR, et al. Treatment of culture pancreatic beta cells with streptozotocin induces cell death by apoptosis. Biosci Rep 1994; 14(4): 243–50

    PubMed  CAS  Google Scholar 

  167. Mustoe TA, Pierce G. Pharmacologic enhancement of wound healing. Ann Rev Med 1995; 46: 467–81

    PubMed  Google Scholar 

  168. Chen GO, Zhu J, Shi XG, et al. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As203) in the treatment of acute promyelocytic leukemia: As203 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood 1996 Aug 1; 88(3): 1052–61

    PubMed  CAS  Google Scholar 

  169. Li L, Nevill G, Forge A. Two modes of hair cell loss from the vestibular sensory epithelia of the guinea pig inner ear. J Comp Neurol 1995; 355(3): 405–17

    PubMed  CAS  Google Scholar 

  170. Kimura S, Maekawa T, Hirakawa K, et al. Alterations of c-myc expression by antisense oligodeoxynucleotides enhance the induction of apoptosis in HL-60 cells. Cancer Res 1995; 55(6): 1379–84

    PubMed  CAS  Google Scholar 

  171. Leonetti C, D’Agnano I, Lo-zupone F, et al. Antitumour effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and in mice. J Natl Cancer Inst 1996; 88: 419–29

    PubMed  CAS  Google Scholar 

  172. Smith MR, Abubakr Y, Mohammad R, et al. Antisense oligodeoxyribonucleotide down regulation of bcl-2 gene expression inhibits growth of the low grade non-Hodgkin’s lymphoma cell line WSH-FSCCL. Cancer Gene Therapy 1995; 2(3): 207–12

    PubMed  CAS  Google Scholar 

  173. Kuo CL, Chou CC, Yung BY. Berberine complexes with DNA in the berberine induced apoptosis in human leukemic HL-60 cells. Cancer Lett 1995; 93(2): 193–200

    PubMed  CAS  Google Scholar 

  174. Hughes DE, Wright KR, Uy HL, et al. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 1995; 10(10): 1478–87

    PubMed  CAS  Google Scholar 

  175. Mentz F, Merle-Boral H, Ouaazf F, et al. Theophylline, a new inducer of apoptosis in B-CC1: role of cyclic nucleotides. Br J Haematol 1995; 90: 957–9

    PubMed  CAS  Google Scholar 

  176. Robertson CN, Robertson KM, Padilla GM, et al. Induction of apoptosis by diethylstilbestrol in hormone insensitive prostate cancer cells. J Natl Cancer Inst 1996 Jul 3; 88(13): 908–17

    PubMed  CAS  Google Scholar 

  177. Rittmaster RS, Norman RW, Thomas IN, et al. Evidence for atrophy and apoptosis in the prostates of given finasteride. J Clin Endocrinol Metab 1996; 81(2): 814–9

    PubMed  CAS  Google Scholar 

  178. Abou-Rabia L, Kendall MD. Involution of the rat thymus in experimentally induced hypothyroidism. Cell Tissue Res 1994; 277(3): 447–55

    PubMed  CAS  Google Scholar 

  179. Traganos F, Kapuscinski J, Gong J, et al. Caffeine prevents apoptosis and cell cycle effects induced by camptothecin or topotecan in HL-60 cells. Cancer Res 1993; 53(19): 4613–8

    PubMed  CAS  Google Scholar 

  180. Belizario JE, Tilly JL, Sherwood SW. Caffeine potentiates the lethality of tumor necrosis factor in cancer cells. Br J Cancer 1993; 67(6): 1229–35

    PubMed  CAS  Google Scholar 

  181. Ray SD, Kamendulus LM, Gurule MW, et al. Ca2+ antagonists inhibit DNA fragmentation and toxic cell death induced by acetaminophen. FASEB J 1993; 7: 453–63

    PubMed  CAS  Google Scholar 

  182. Pahor M, Guralnik JM, Ferrucci L, et al. Calcium channel blockade and incidence of cancer in aged populations. Lancet 1996; 348: 493–7

    PubMed  CAS  Google Scholar 

  183. Jick H, Jick S, Derby LE, et al. Calcium channel blockers and risk of cancer. Lancet 1997; 349: 525–8

    PubMed  CAS  Google Scholar 

  184. Kondo S, Yin D, Morimura T, et al. Combination therapy with cisplatin and nifedipine inducing apoptosis in multidrug-resistant human glioblastoma cells. J Neurosurg 1995; 82: 469–74

    PubMed  CAS  Google Scholar 

  185. Boolbol SK, Dannenberg AJ, Chadburn A, et al. Cyclooxygenase-2 overexpression and tumour formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res 1996; 56(11): 2556–60

    PubMed  CAS  Google Scholar 

  186. Pasricha PJ, Bedi A, O’Connor K, et al. The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology 1995; 109(3): 994–8

    PubMed  CAS  Google Scholar 

  187. Indap MA, Rao SGA. Cell death by apoptosis and cancer chemotherapy. Natl Med J India 1995; 8(2); 65–7

    PubMed  CAS  Google Scholar 

  188. Bussing A, Suzart K, Bergmann J, et al. Induction of apoptosis in human lymphocytes treated with viscum album L is mediated by the mistletoe lectins. Cancer Lett 1996; 99: 59–72

    PubMed  CAS  Google Scholar 

  189. Thatte UM, Dahanukar SA. Comparative study of immunomodulating activity of Indian medicinal plants, lithium carbonate and glucan. Methods Find Exp Clin Pharm 1988; 10: 639–44

    CAS  Google Scholar 

  190. Thatte UM, Dahanukar SA. Immunotherapeutic modification of diverse infectious states by Indian medicinal plants. Phytotherapy Res 1989; 3(2): 43–9

    Google Scholar 

  191. Thatte UM, Dahanukar SA, Rao SGA. Tinospora cordifolia induces production of GM-CSF. J Postgrad Med 1994; 40(4): 202–3

    PubMed  CAS  Google Scholar 

  192. Maneckgee R, Minna JD. Opioids induce while nicotine suppresses apoptosis in human lung cancer cells. Cell Growth Differ 1994; 5: 1033–40

    Google Scholar 

  193. Grindley J. Apoptosis — death under review. Scrip 1994 Jul/Aug; 42–5

  194. Akhtar S, Agrawal S. In vivo studies with antisense oligonucleotides. Trends Pharmacol Sci 1997; 18(1): 12–8

    PubMed  CAS  Google Scholar 

  195. Nicotera P, Brune B, Bagetta G. Nitric oxide: inducer or suppressor of apoptosis? Trends Pharmacol Sci 1997; 18(6): 189–90

    PubMed  CAS  Google Scholar 

  196. Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the human heart. N Engl J Med 1997; 336: 1131–41

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Seth GS Medical College, Parel Mumbai, 400 012, India

    Urmila Thatte (Associate Professor) & Sharadini Dahanukar

Authors
  1. Urmila Thatte
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sharadini Dahanukar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Urmila Thatte.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thatte, U., Dahanukar, S. Apoptosis. Drugs 54, 511–532 (1997). https://doi.org/10.2165/00003495-199754040-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199754040-00002

Keywords

Search

Navigation